Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,765 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.
Ando Y, Nishiyama H, Shimodaira H, Takano N, Sakaida E, Matsumoto K, Nakanishi K, Sakai H, Tsukamoto S, Komine K, Yasuda Y, Kato T, Fujiwara Y, Koyama T, Kitamura H, Kuwabara T, Yonezawa A, Okumura Y, Yakushijin K, Nozawa K, Goto H, Matsubara T, Hoshino J, Yanagita M; Committee of Clinical Practice Guidelines for the Management of Kidney Disease During Anticancer Drug Therapy 2022. Ando Y, et al. Int J Clin Oncol. 2023 Oct;28(10):1315-1332. doi: 10.1007/s10147-023-02382-2. Epub 2023 Jul 16. Int J Clin Oncol. 2023. PMID: 37453935
Carboplatin dosing for adult Japanese patients.
Ando Y, Shimokata T, Yasuda Y, Hasegawa Y. Ando Y, et al. Nagoya J Med Sci. 2014 Feb;76(1-2):1-9. Nagoya J Med Sci. 2014. PMID: 25129986 Free PMC article. Review.
Extension of the Calvert formula to patients with severe renal insufficiency.
Oguri T, Shimokata T, Ito I, Yasuda Y, Sassa N, Nishiyama M, Hamada A, Hasegawa Y, Ando Y. Oguri T, et al. Among authors: ando y. Cancer Chemother Pharmacol. 2015 Jul;76(1):53-9. doi: 10.1007/s00280-015-2769-9. Epub 2015 May 10. Cancer Chemother Pharmacol. 2015. PMID: 25957958 Clinical Trial.
Obvious Pitfall in the Estimation of Renal Dysfunction.
Shimokata T, Yasuda Y, Ando Y. Shimokata T, et al. Among authors: ando y. J Clin Oncol. 2016 Jul 10;34(20):2429. doi: 10.1200/JCO.2015.65.9243. Epub 2016 May 16. J Clin Oncol. 2016. PMID: 27185841 No abstract available.
Guidelines for treatment of renal injury during cancer chemotherapy 2016.
Horie S, Oya M, Nangaku M, Yasuda Y, Komatsu Y, Yanagita M, Kitagawa Y, Kuwano H, Nishiyama H, Ishioka C, Takaishi H, Shimodaira H, Mogi A, Ando Y, Matsumoto K, Kadowaki D, Muto S. Horie S, et al. Among authors: ando y. Clin Exp Nephrol. 2018 Feb;22(1):210-244. doi: 10.1007/s10157-017-1448-z. Clin Exp Nephrol. 2018. PMID: 28856465 Free PMC article. Review. No abstract available.
A nationwide, cross-sectional, web-based survey on healthcare providers' knowledge about, attitudes toward, and perceived barriers to adherence to clinical practice guidelines for anticancer drug therapy for older patients with cancer in Japan.
Matsuoka A, Shimazu T, Takahashi M, Nagashima F, Nishiyama H, Fujimori M, Ando Y. Matsuoka A, et al. Among authors: ando y. J Geriatr Oncol. 2023 Jan;14(1):101399. doi: 10.1016/j.jgo.2022.10.014. Epub 2022 Nov 7. J Geriatr Oncol. 2023. PMID: 36357276
2,765 results